(NYSE: EVH) Evolent Health's forecast annual revenue growth rate of 17.3% is forecast to beat the US Health Information Services industry's average forecast revenue growth rate of 6.77%, and it is also forecast to beat the US market's average forecast revenue growth rate of 12.15%.
Evolent Health's revenue in 2026 is $2,342,852,000.On average, 16 Wall Street analysts forecast EVH's revenue for 2026 to be $300,408,258,464, with the lowest EVH revenue forecast at $277,108,521,550, and the highest EVH revenue forecast at $316,808,558,719. On average, 16 Wall Street analysts forecast EVH's revenue for 2027 to be $375,171,006,523, with the lowest EVH revenue forecast at $318,505,141,504, and the highest EVH revenue forecast at $410,799,245,008.
In 2028, EVH is forecast to generate $419,734,581,009 in revenue, with the lowest revenue forecast at $373,474,423,738 and the highest revenue forecast at $468,822,376,255.